dc.contributor.author
Corman, Victor M.
dc.contributor.author
Landt, Olfert
dc.contributor.author
Kaiser, Marco
dc.contributor.author
Molenkamp, Richard
dc.contributor.author
Meijer, Adam
dc.contributor.author
Chu, Daniel K. W.
dc.contributor.author
Bleicker, Tobias
dc.contributor.author
Brünink, Sebastian
dc.contributor.author
Schneider, Julia
dc.contributor.author
Schmidt, Marie Luisa
dc.contributor.author
Mulders, Daphne G. J. C.
dc.contributor.author
Haagmans, Bart L.
dc.contributor.author
van der Veer, Bas
dc.contributor.author
van den Brink, Sharon
dc.contributor.author
Wijsman, Lisa
dc.contributor.author
Goderski, Gabriel
dc.contributor.author
Romette, Jean-Louis
dc.contributor.author
Ellis, Joanna
dc.contributor.author
Zambon, Maria
dc.contributor.author
Peiris, Malik
dc.contributor.author
Goossens, Herman
dc.contributor.author
Reusken, Chantal
dc.contributor.author
Koopmans, Marion P. G.
dc.contributor.author
Drosten, Christian
dc.date.accessioned
2020-02-28T17:24:04Z
dc.date.available
2020-02-28T17:24:04Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/26791
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-26548
dc.description.abstract
Background: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project. Conclusion: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
novel coronavirus
en
dc.subject
Coronavirus SARS-CoV-2
de
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
2000045
dcterms.bibliographicCitation.doi
10.2807/1560-7917.ES.2020.25.3.2000045
dcterms.bibliographicCitation.journaltitle
Eurosurveillance
dcterms.bibliographicCitation.number
3
dcterms.bibliographicCitation.originalpublishername
European Centre for Disease Prevention and Control
dcterms.bibliographicCitation.volume
25
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31992387
dcterms.isPartOf.eissn
1560-7917